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Introduction

Tables

Warm autoimmune hemolytic anemia (WAIHA) can be a life threatening entity
if complicated by hypersplenism and reticulocytopenia. Overall, this is an
infrequent complication. Here we present a case of WAIHA showing a drastic
response to partial splenic artery embolization (PSAE).

Hypersplenism and/or reticulocytopenia are infrequent complications
of a warm autoimmune hemolytic anemia, constituting a life
threatening complication that may not respond to standard therapy
and may not qualify for surgical intervention1. The above patient did
not improve with any medical therapies, continued with a decreasing
trend in hemoglobin that was accompanied by increasing lactate levels
with no elevated troponin or signs of cardiac compromise. PSAE
achieved a dramatic response that was maintained through follow up.
Diﬀerent embolic agents can be used including gelatin sponge
pledgets, coils, plugs and microspheres. Techniques between diﬀerent
centers varies greatly but the Spigos technique has been shown to
reduce complications2.

Hospital Course
A 27 year old male with no significant past medical history presented to an
outside hospital for chief complaints of nausea/vomiting, epigastric pain, and
acute jaundice. Initial laboratory workup revealed a hemoglobin of 5.5 g/dl,
normal WBC and platelet count, elevated direct bilirubin (10 mg/dl), elevated
lactate dehydrogenase (969 IU/L), low haptoglobin (<8 mg/dl), the peripheral
smear revealed rare polychromasia and spherocytes, a positive direct
antiglobulin test (DAT: BS +, IgG +, C3d -) with presence of warm
autoantibodies. All infectious disease testing was negative. Anti nuclear
antibodies were not identified. The initial CT abdomen showed a normal sized
spleen. The patient was diagnosed with idiopathic warm autoimmune
hemolytic anemia and was treated with pulsed steroids, one dose of
Rituximab, and transfused with a total of 13 units packed red blood cells. The
patient did not respond to medical treatment, and after one week, the patient
was transferred to our institution for escalation of care.
At our institution, Transfusion Medicine was consulted and advised only
transfusion of phenotypically matched pack red blood cells for significantly
symptomatic anemia or hemodynamic instability, as the patient continued a
downtrend in the hemoglobin despite continued transfusion support. Decadron
was added to his therapy, as well as IVIG that needed to be discontinued due
to infusion related shortness of breath and chest pain. Another dose of Rituxan
along with vincristine and cyclophosphamide were also given. Despite these
efforts, the patient’s hemoglobin continued to drop despite an additional 9
RBC units transfused at our institution, reaching a low of 2.1 g/dl. In addition,
the patient developed left lower quadrant pain accompanied by bloody bowel
movements. A repeat CT scan of the abdomen was performed, which revealed
an enlarged spleen with a span of 16.5 cm in its maximum dimension. As the
patient was not a candidate for splenectomy, partial splenic artery embolization
(PSAE) was performed.
The lower to mid portions of the spleen were embolized individually with
500-700 micrometer Embosphere microspheres followed with a gelfoam/
contrast slurry mixed with gentamicin. Thirty percent residual viable spleen was
seen on the final digital subtraction angiography (DSA). Six hours post
procedure, a dramatic increase in hemoglobin was observed without any
additional transfusion support. The patient suﬀered severe left upper quadrant
abdominal pain that was controlled medically. After close observation, the
patient was discharged home 2 days later. At home the patient was doing well
symptomatically with the exception of persistent left upper quadrant pain. He
had no clinical or laboratory signs of recurrent hemolysis. Hemoglobin was
12.1 g/dl. 3 months after embolization, patient underwent laparoscopic
splenectomy due to persistent left upper quadrant pain. During this
hospitalization a type and screen was performed in preparation for surgery. No
warm autoantibodies were detected; however, additional new alloantibodies
were identified.

Discussion

Potential complications that can result from the procedure include
pleural eﬀusion, pancreatitis, paralytic ileus, or post-embolization
syndrome2. Post-embolization syndrome can consist of leukocytosis,
fever, and continued abdominal pain3. Due to recurrent pain from the
embolization, our patient eventually received a splenectomy once he
was stable.
In summary, we show that partial splenic artery embolization can be a
safe and eﬀective therapy for managing medication refractory warm
autoimmune hemolytic anemia in patients who are at high risk for
surgery.
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